Navigation Links
Targeting Sugar on Blood Vessels may Inhibit Cancer Growth

In a study that could point to novel therapies to prevent cancer spread, or metastasis, researchers at the University of California, San Diego (UCSD) School of Medicine have targeted a sugar that supports blood vessel growth in the tumor.

Lung cancer is the most common cause of cancer death and an area where novel therapies to block metastasis are desperately needed, according to first author Mark M. Fuster, M.D., assistant professor in the Division of Pulmonary and Critical Care Medicine in UCSDs Department of Medicine. Solid tumors need a network of blood vessels, or vasculature, in order to grow, and this vasculature drives metastasis. The research team, led by the papers principal investigator Jeffrey D. Esko, Ph.D., professor of Cellular and Molecular Medicine at UCSD, showed that modifying the action of heparan sulfate uniquely impacted the tumor vasculature, and in doing so, altered the growth rate of tumors prepared from lung carcinoma cells in the mice.

"We theorized that by targeting the sugar, heparan sulfate, we could affect angiogenesis, which is the formation of new blood vessels," said Fuster. "In cancer, angiogenesis sustains growth as well as metastasis of tumors. An important finding was that, not only could we inhibit the growth of tumors in these mice, but that other systems that rely on endothelial growth, such as the reproductive system and wound healing, remained robust."

Studying mouse models with a genetic alteration in an important sugar-modifying enzyme (Ndst1), the researchers saw a marked decrease in the growth of experimental carcinomas. The Ndst1 enzyme is responsible for modifying the molecular structure of a sugar called heparan sulfate. In endothelial cells, this sugar facilitates the action of several important vascular growth factors that support angiogenesis.

An antibody drug called Avastin, produced by Genentech, has been shown to block a major pro-angiogenesis molecule ca
'"/>




Page: 1 2

Related medicine news :

1. Novel Technique For Targeting Small-Cell Lung Cancer
2. Targeting PARP1 Is Effective In Protecting HD Cells from Damage
3. Ad Campaign Targeting Republicans On Medicare Prescription Drug Program
4. By Targeting Specific Germs, Hospital Hopes to Improve Pneumonia Treatment
5. Highly Potent TB Strain Plays Favorites Targeting Specific Ethnic Groups
6. New Asthma Medicine Targeting Vulnerable Inner-City Children Tested
7. Targeting a Single Gene Could Inhibit Bone Decay and Stimulate Bone Growth
8. Researchers Find Stem-cell Therapy Effective in Targeting Metastatic Cancer
9. Targeting the Adrenal Gland Could Be Key Against Heart Failure
10. Targeting SOCS-3 can Control Obesity
11. Sex Abstinence Programs Targeting School-goers may Not Produce Desired Effect , Study
Post Your Comments:
(Date:10/6/2008)... Millions of women suffer with symptoms of men...conomic rescue plan. But the effects of our curren...aking it increasingly difficult for U.S. women to ...kstead announces new cost effective drug-free guid...a prescription. , Las Veg...
(Date:10/6/2008)..., Oct. 6 /PRNewswire-FirstCall/ -- SAP AG (NYSE: ...ed SAP as senior vice president,of the Healthcare ...e,August 1, 2008, Mr. Papandrea will help drive SA...egic software solutions to healthcare,organization...onjunction,with the 3rd annual Ambassadors Dinner ...
(Date:10/5/2008)...e blood test may help detect serious bacterial inf...lood stream infections in young infants who come t...ave no clear cause. Researchers at Children,s Hosp...eorge Washington University, show that a new diagn...y infants at high risk for SBIs while potentially ...
(Date:10/5/2008)...ittle exercise goes a long way toward helping seve...fe and complete important daily tasks, according t... , In a pre-program assessment where patients re...e per week, individuals who were more active repor...rted improvements in their ability to perform dail...
Breaking Medicine News(10 mins):Health News:Menopause Relief: Award-Winning Physician Announces New Cost Effective Drug-Free Guidelines 2Health News:Menopause Relief: Award-Winning Physician Announces New Cost Effective Drug-Free Guidelines 3Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 2Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 3Health News:New test could help catch serious infections in babies 2Health News:A little exercise goes a long way for severely obese 2
...lds of academia, research, government and industry...of-the-art// communications technology can make he...an emerging field that encompasses a range of heal...ectronic medical records, telemedicine, citizen-or...
...the National Rural Health Mission (NHRM) of India ...ogrammes.// The funds will be allocated through U...pecific activities. The governments of India and ...i-partner initiative Tuesday here for achieving th...
...and those affected by HIV/AIDS, a Community Based ...ai Vizhuthugal' (Tamil Nadu AIDS Initiative Roots)...m Coimbatore, Madurai, Vellore, Salem and Chennai,...g the community to undertake and develop skills fo...
...al to expand price control from 74 to 354 drugs in...dustry chamber CII today said the step will prove ...as the economy. "Healthy competition between phar...le pricing. Instead of affecting the growth by ove...
Other Medicine News:Health News:Delhi to Host E-health Global Meet Next Month 2Health News:Norway Grants $80 mn to India's Health Mission 2
(Date:10/6/2008)...EW, Calif. and SEATTLE, Oct. 6 /- Com...ation human genome sequencing,company, and the Ins...heir,partnership to conduct populationwide human g...lete Genomics will use its proprietary,DNA sequenc...es provided by,ISB. Then, once proof-of-concept ha...
(Date:10/6/2008)...Procedure May Eliminate 6 Weeks of Radiation Thera... over the Internet Wednesday, October 22, 2008,...plorehealth , HAMPTON, Va., Oct. 6 /... was diagnosed with breast cancer in May. Would sh... about radiation or chemotherapy?, , To view the...
(Date:10/5/2008)...lished in New England Journal of Medicine reaffirm...ofile of SPIRIVA(R),HandiHaler(R), RIDGEFIELD, Co...of the,UPLIFT (Understanding Potential Long-term I...that SPIRIVA(R) HandiHaler(R) (tiotropium bromide,... function for up to 4,years as measured by FEV(1) ...
(Date:10/3/2008)... to Study B-Raf Kinase Inhibitors for Cancer Treat.... 3 /-,Eli Lilly and Compan...aceuticals, LLC today announced that the two compa...de licensing agreement related to,Deciphera,s prec...dy of,potential oncology therapeutics., The colla...
Breaking Medicine Technology:Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 4Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 6Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement 2Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement 3Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals LLC 4510 1Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals LLC 4510 2Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals LLC 4510 3Commerzbank Goes Live With Misys Risk Vision 5 4 Following a Successful On Schedule Implementation Project 16446 1Commerzbank Goes Live With Misys Risk Vision 5 4 Following a Successful On Schedule Implementation Project 16446 2Researchers pilot new electronic system for infectious illness 16444 1Researchers pilot new electronic system for infectious illness 16444 2Carbon nanotubes made into conductive flexible stained glass 4504 1Carbon nanotubes made into conductive flexible stained glass 4504 2
...1, 2007 - Opexa,Therapeutics, Inc. (NASDAQ:OPXA), ...alization of cell therapies, made a poster,present... of,Clinical Immunology Societies (FOCIS) in San D...p; Marina. The poster, entitled,"Identifying New I...ng Multiple Sclerosis Patients" was presented on S...
...t Federation of,Clinical Immunology Societies (FOC...007 /PRNewswire-FirstCall/ --,Orchestra Therapeuti...sitive new data from its completed Phase II open-l...ell Receptor (TCR) peptide,vaccine for the treatme... The new data, presented last week at the Federati...
Other Medicine Technology:Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 2Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 3Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 2Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 3Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 5
Bacon Bone Rongeur
Schell Rongeur
Zaufal-Jansen Ronguer
Ruskin Mini-Bone Rongeur
Medicine Products: